Hookipa Biotech AG

Hookipa Biotech AG is developing a new class of innovative immunotherapeutics and vaccines based on its proprietary Vaxwave® technology. The Vaxwave® technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases.

  • Ausrichtungen
    • Therapie-Entwickler
  • Gegründet

    2011
  • Aktualisiert am

    30.05.2018